RESUMEN
OBJECTIVE: Craniovertebral junction (CVJ) abnormalities are common and well documented in mucopolysaccharidosis type I-Hurler syndrome (MPS IH), often causing severe spinal canal narrowing. However, the requirement for surgical decompression and/or fusion is uncommon. Although hematopoietic cell transplant (HCT) has been shown to prolong the lives of patients with MPS IH, its effect in halting or reversing musculoskeletal abnormalities is less clear. Unfortunately, there are currently no universal guidelines for imaging or indication for surgical interventions in these patients. The goal of this study was to track the progression of the CVJ anatomy in patients with MPS IH following HCT, and to examine radiographic features in patients who needed surgical intervention. METHODS: Patients with MPS IH treated at the University of Minnesota with allogeneic HCT between 2008 and 2020 were retrospectively reviewed. Patients who underwent CVJ surgery were identified with chart review. All MPS IH cervical scans were examined, and the odontoid retroflexion angle, clivoaxial angle (CXA), canal width, and Grabb-Oakes distance (pB-C2) were measured yearly for up to 7 years after HCT. Longitudinal models based on the measurements were made. An intraclass correlation coefficient was used to measure interrater reliability. Nine children without MPS IH were examined for control CVJ measurements. RESULTS: A total of 253 cervical spine MRI scans were reviewed in 54 patients with MPS IH. Only 4 (7.4%) patients in the study cohort required surgery. Three of them had posterior fossa and C1 decompression, and 1 had a C1-2 fusion. There was no statistically significant difference in the spinal parameters that were examined between surgery and nonsurgery groups. Among the measurements, canal width and CXA varied drastically in patients with different neck positions. Odontoid retroflexion angle and CXA tended to decrease with age. Canal width and pB-C2 tended to increase with age. CONCLUSIONS: Based on the data, the authors observed an increase in canal width and pB-C2, whereas the CXA and odontoid retroflexion angle became more acute as the patients aged after HCT. The longitudinal models derived from these data mirrored the development in children without MPS IH. Spinal measurements obtained on MR images alone are not sufficient in identifying patients who require surgical intervention. Symptom monitoring and clinical examination, as well as pathological spinal cord changes on MRI, are more crucial in assessing the need for surgery than is obtaining serial imaging.
Asunto(s)
Mucopolisacaridosis I , Humanos , Masculino , Femenino , Mucopolisacaridosis I/complicaciones , Mucopolisacaridosis I/cirugía , Mucopolisacaridosis I/diagnóstico por imagen , Mucopolisacaridosis I/patología , Preescolar , Niño , Estudios Retrospectivos , Adolescente , Lactante , Trasplante de Células Madre Hematopoyéticas , Descompresión Quirúrgica/métodos , Progresión de la Enfermedad , Vértebras Cervicales/cirugía , Vértebras Cervicales/diagnóstico por imagen , Adulto JovenRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Lactante , Mucopolisacaridosis I/complicaciones , Insuficiencia Cardíaca/complicaciones , Infecciones por Coronavirus/complicaciones , Cardiomiopatía Dilatada/complicaciones , Antagonistas de Receptores de Angiotensina/uso terapéutico , Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo/patogenicidad , Reacción en Cadena de la Polimerasa/métodos , Antagonistas de Receptores de Angiotensina/efectos adversos , Resultado FatalRESUMEN
ABSTRACT INTRODUCTION: Mucopolysaccharidosis (MPS) is a lysosomal storage disease caused by deficiency of a-l-iduronidase. The otolaryngological findings include hearing loss, otorrhea, recurrent otitis, hypertrophy of tonsils and adenoid, recurrent rhinosinusitis, speech disorders, snoring, oral breathing and nasal obstruction. OBJECTIVE: To evaluate the impact of enzymatic replacement therapy with laronidase (Aldurazyme(r)) in patients with mucopolysaccharidosis (MPS I), regarding sleep and hearing disorders, and clinical manifestations in the upper respiratory tract (URT). METHODS: Nine patients with MPS I (8 Hurler-Scheie, and 1 Scheie phenotypes) of both sexes, ages ranging between 3 and 20 years, were included in this study. Patients were evaluated between seven and 11 months before the treatment and between 16 and 22 months after the onset of the enzymatic replacement. They were all submitted to a clinical and otolaryngological evaluation, including nasofibroscopical, polysomnographic and audiologic exams. RESULTS: The results' data showed decreasing of the frequency of ear, nose and throat infections, with improvement of the rhinorrhea and respiratory quality. No remarkable changes were observed regarding macroglossia and tonsil and adenoid hypertrophy. Audiometric and polysomnographic evaluations did not show statistical significance. CONCLUSION: Enzymatic replacement therapy in patients with mucopolysaccharidosis I provides control of recurrent URT infections, rhinorrhea and respiratory quality, however it is does not seem to improve audiologic and polisomnographic parameters, with no effect on adenoid and tonsils hypertrophy and macroglossia.
Resumo Introdução: Mucopolissacaridose (MPS) é uma doença de depósito lisossômico causada pela deficiência de a-l-iduronidase. Os achados otorrinolaringológicos incluem perda auditiva, otorreia, otites de repetição, hipertrofia adenotonsilar, rinossinusite recorrente, distúrbios da fala, roncos, respiração bucal e obstrução nasal. Objetivo: Avaliar o impacto da terapia de reposição enzimática com laronidase (Aldurazyme(r)) em pacientes com mucopolissacaridose I (MPS I) em relação ao sono, distúrbios auditivos e manifestações clínicas do trato respiratório superior (TRS). Método: Nove pacientes com MPS I (oito com fenótipo Hurler-Scheie e um com fenótipo Scheie), de ambos os sexos, com idades variando entre 3 e 20 anos, foram incluídos neste estudo. Os pacientes foram avaliados entre 7 e 11 meses antes do tratamento e entre 16 e 22 meses após o início da substituição enzimática. Todos foram submetidos a uma avaliação clínica e otorrinolaringológica, incluindo nasofibroscopia, polissonografia e exames radiológicos. Resultados: Os dados dos resultados mostraram diminuição da frequência de infecções de orelha, nariz e garganta, com melhora da rinorreia e da qualidade respiratória. Mudanças significativas não foram observadas em relação à macroglossia e à hipertrofia adenotonsilar. Avaliações audiométricas e polissonográficas não apresentaram significância estatística. Conclusão: A terapia de reposição enzimática em pacientes com mucopolissacaridose I fornece controle de infecções recorrentes do TRS, rinorreia e qualidade respiratória, porém, não parece melhorar os parâmetros audiológicos e polissonográficos, ou exercer efeito sobre a hipertrofia adenotonsilar e macroglossia.
Asunto(s)
Humanos , Masculino , Femenino , Preescolar , Niño , Adolescente , Adulto Joven , Enfermedades Otorrinolaringológicas/tratamiento farmacológico , Mucopolisacaridosis I/tratamiento farmacológico , Terapia de Reemplazo Enzimático , Iduronidasa/uso terapéutico , Enfermedades Otorrinolaringológicas/etiología , Resultado del Tratamiento , Mucopolisacaridosis I/complicacionesRESUMEN
Se realiza una presentación de un caso interesante, no comúnmente visto en la práctica médica, de unos de los tipos de mucopolisacaridosis, específicamente de un síndrome de Hunter. Se hace esta presentación con el objetivo de dar a conocer a estudiantes y profesionales de la salud, mediante fotos, las características físicas del paciente con dicho sídrome, quien llegó desnutrido al hospital; se le operó de la hernia umbilical y se mejoró su estado nutricional al compensarse su hepatopatía. Se le da el alta médica en mejores condiciones(AU)
We present here an interesting case of mucopolysaccharidoses, which is not commonly seen in medical practice, specifically a Hunter syndrome. This presentation is done in order to make known to students and health professionals, through photos, the physical characteristics of the patient with such syndrome. This patient arrived malnourished at the hospital, he was operated on the umbilical hernia and improved his nutritional status by compensating for his liver disease. This patient had medical discharge in better conditions(AU)
Asunto(s)
Humanos , Mucopolisacaridosis/complicaciones , Mucopolisacaridosis/cirugía , Mucopolisacaridosis/terapia , Mucopolisacaridosis II/complicaciones , Mucopolisacaridosis I/complicaciones , Mucopolisacaridosis III/complicacionesRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Niño , Mucopolisacaridosis I/complicaciones , Mucopolisacaridosis I/diagnóstico , Mucopolisacaridosis I/tratamiento farmacológico , Anestesia/métodos , Anestesiología/instrumentación , Mucolipidosis/complicaciones , Mucolipidosis/tratamiento farmacológico , Anestesiología/normasRESUMEN
Introduction: Mucopolysaccharidoses (MPS) are a group of inherited disorders due to lysosomal enzyme deficiencies. The aims of this study are to describe the neuroimaging findings in children evaluated in our hospital with this diagnosis, looking for a possible correlation of these alterations with the type of MPS and clinical severity, and finally to compare these findings with those previously reported. Material and methods: We retrospectively analysed the medical records of 19 patients who had been diagnosed with MPS between 1992 and 2010: 7 had type I (5 with Hurler syndrome and 2 with Hurler-Scheie syndrome), 10 had type II or Hunter syndrome (4 with the severe form and 6 with the mild form), 1 had type III or Sanfilippo syndrome and 1 had type VI or Maroteaux-Lamy syndrome. We assessed the brain neuroimaging studies: computed axial tomography (CAT) in 5 patients, and magnetic resonance imaging (MRI) in 15. Results: We observed a broad spectrum of neuroimaging anomalies. In CAT: mega cisterna magna (3/5, 60%). In brain MRI: dilated Virchow-Robin perivascular spaces (11/15, 73%), white matter abnormalities (11/15, 73%), and ventriculomegaly (5/15, 33%). Conclusions: Abnormal findings in neuroimaging studies are frequent in MPS (dilated Virchow-Robin perivascular spaces, white matter abnormalities and ventriculomegaly). Thus, given these abnormalities we should be aware of this possible diagnosis, particularly when typical signs and symptoms are present. However, we did not find a correlation between these findings and either any specific type of MPS or clinical severity (AU)
Introducción: Las mucopolisacaridosis (MPS) son un grupo de enfermedades hereditarias de depósito lisosomal. El objetivo de esta revisión es describir las alteraciones neurorradiológicas en los niños evaluados en nuestro hospital con este diagnóstico, buscar la posible correlación de estas alteraciones con el tipo de MPS y con la gravedad clínica, y comparar nuestros hallazgos con lo descrito en la literatura. Material y métodos:Revisamos retrospectivamente las historias clínicas de 19 pacientes diagnosticados de MPS en el periodo 1992-2010: 7 tipo I (5 con síndrome de Hurler y 2 con Hurler-Scheie), 10 tipo II o síndme de Hunter (4 con la forma grave y 6 con la moderada), 1 tipo III o síndrome de Sanfilippo y 1 tipo VI o síndrome de Maroteaux-Lamy. Se analizaron las pruebas de neuroimagen: tomografía computarizada (TC) en 5 pacientes y resonancia magnética craneal (RMC) en 15. Resultados: Encontramos un amplio espectro de alteraciones radiológicas. En la TC destaca la megacisterna magna (3/5, 60%); en la RMC el aumento de los espacios perivasculares (11/15, 73%), la alteración parcheada de la sustancia blanca (SB) (11/15, 73%) y la ventriculomegalia (5/15, 33%).Conclusiones: Algunas anomalías neurorradiológicas son frecuentes en las MPS (aumento de los espacios perivasculares, alteraciones de la SB, ventriculomegalia), por lo que ante estos hallazgos debemos investigar esta posibilidad diagnóstica, especialmente en pacientes con clínica compatible. No hemos hallado datos específicos de cada tipo de MPS, ni relación de estas alteraciones radiológicas con la gravedad de la forma clínica (AU)
Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Niño , Mucopolisacaridosis/complicaciones , Enfermedades del Sistema Nervioso/etiología , Neuroimagen/métodos , Estudios Retrospectivos , Mucopolisacaridosis I/complicaciones , Mucopolisacaridosis II/complicaciones , Factores de RiesgoRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Femenino , Enfermedades por Almacenamiento Lisosomal/complicaciones , Enfermedades por Almacenamiento Lisosomal/diagnóstico , Enfermedades por Almacenamiento Lisosomal/terapia , Pronóstico , Mucopolisacaridosis I/complicaciones , Mucopolisacaridosis I/diagnóstico , Oftalmopatías/complicaciones , Oftalmopatías/diagnóstico , Indicadores de Morbimortalidad , Enfermedad de Fabry/complicaciones , Enfermedad de Fabry/diagnósticoRESUMEN
Um menino de oito anos de idade, mulato, com quadro clínico e achados laboratoriais característicos da síndrome de Hunter, foi encaminhado à Universidade de Imunopatologia por apresentar infecçöes respiratórias superiores recorrentes e asma grave. Os exames laboratoriais mostraram número normal de leucócitos periféricos, níveis séricos de IgG e IgM normais. IgA sérica e salivar indetectáveis, títulos de isohemaglutinas séricas normais e teste de Schick negativo. Os testes cutáneos de hipersensibilidade tardia foram positivos para Candidina e Tricofitina e o estudo das subpopulaçöes de linfócitos T e B através de técnicas de imunofluorescência mostrou valores dentro dos limites normais. O defeito de secreçäo de IgA é interpretado como sendo decorrente de um bloqueio no estágio final de maturaçäo das células B e, a associaçäo de deficiência seletiva de IgA com a síndrome de Hunter como sendo uma ocorrência casual